会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • ORGANIC LIGHT EMITTING SYSTEMS
    • 有机发光系统
    • WO2009092671A2
    • 2009-07-30
    • PCT/EP2009/050494
    • 2009-01-16
    • CIBA HOLDING INC.CHEBOTAREVA, NataliaPRÉTÔT, RogerWOLLEB, AnnemarieWOLLEB, Heinz
    • CHEBOTAREVA, NataliaPRÉTÔT, RogerWOLLEB, AnnemarieWOLLEB, Heinz
    • C09K11/06H05B33/14C07F15/00
    • C09K11/06C07F15/0033H05B33/14H05B33/28
    • Novel electrophosphorescent copolymers of the composition [A 1 ] x1 , [A 2 ] x2 , [A 3 ] x3 , [A 4 ] x4 , [A 5 ] x5 wherein the structural units A 1 , A 2 , A 3 , A 4 and/or A 5 are in blocks or at random, and the copolymer is linear or crosslinked, and A 1 is an organic radical of a phosphorescent light emitting moiety; A 2 is an organic radical providing host functionality; A 3 is an organic radical providing electron transport functionality; A 4 is an organic radical providing hole transport functionality; A 5 is a radical derived from aliphatic or aromatic organic monomers; x1 is a number from 1 to about 1000; x2, x3, x4 and x5 independently are numbers from 0 to about 100 000, with the proviso that the sum (x1 + x2 + x3 + x4 + x5) is at least 5, especially greater than 9; are characterized in that A 1 contains a metal benzotriazole complex moiety or A 2 is selected from repeating unit(s) of the formulae (III), (IV), where the symbols are as defined in claim 1. The novel copolymers are useful as active materials e.g. in electroluminescent devices.
    • 新的电致磷光共聚物组合物[A 1] x 1,[A 2] x 2 x 2, [A 3],[A 4],[A 5],[A 5],[A 5] 其中结构单元A 1,A 2,A 3,A ,其中结构单元A 1,A 2,A 3,A > 4和/或A 5是嵌段或无规共聚物,并且共聚物是线性的或交联的,并且A 1是磷光的有机基团 发光部分; A 2是提供主体官能团的有机基团; A 3是提供电子传输官能团的有机基团; A 4是提供空穴传输功能的有机基团; A 5是衍生自脂族或芳族有机单体的基团; x1是从1到约1000的数字; (x1 + x2 + x3 + x4 + x5)至少为5,尤其大于9; x2,x3,x4和x5各自独立地为0至约100000的数字,条件是总和 其特征在于A 1包含金属苯并三唑络合物部分或A 2选自式(III),(IV)的重复单元,其中 符号如权利要求1中所定义。新型共聚物可用作活性物质, 在电致发光器件中。
    • 9. 发明申请
    • MEROCYANINE DERIVATIVES
    • WO2006003094A2
    • 2006-01-12
    • PCT/EP2005/052850
    • 2005-06-20
    • CIBA SPECIALTY CHEMICALS HOLDING INC.WAGNER, BarbaraBIENEWALD, FrankWOLLEB, HeinzWALLQUIST, OlofHERZOG, BerndEHLIS, ThomasHAASE, Jürg
    • WAGNER, BarbaraBIENEWALD, FrankWOLLEB, HeinzWALLQUIST, OlofHERZOG, BerndEHLIS, ThomasHAASE, Jürg
    • A61K7/42
    • A61K8/498A61K8/4913A61K8/494A61Q17/04
    • Disclosed is the use of merocyanine derivatives of formula (I), wherein Q is hydrogen; C 1 -C 22 alkyl; -OH; -OR 7 ; -NR 7 R 8 ; or -N=R 9 ; R 1 is hydrogen; C 1 -C 22 alkyl; -OR 7 , -SR 7 ; -NR 7 R 8 ; C 1 -C 22 alkyl; C 2 -C 12 alkenyl; C 2 -C 12 alkinyl; C 3 -C 12 cycloalkyl; C 3 -C 12 cycloalkenyl; C 7 -C 12 aralkyl; C 1 -C 12 heteroalkyl, C 2 -C 11 heteroaralkyl; C 6 -C 10 aryl; or C 1 -C 9 heteroaryl; R 4 is cyano; COR 7 , COOR 7 ; CONR 7 R 8 ; SO 2 (C 6 -C 12 )aryl; C 2 -C 12 alk-1-enyl; C 3 -C 12 cycloalk-1-enyl; C 2 -C 12 alk-1-inyl; C 2 -C 12 heteroalkyl; C 3 -C 5 heterocycloalkyl; C 6 -C 10 aryl; or C 1 -C 9 heteroaryl; R 5 is -COR 7 ; -COOR 7 ; -OR 7 ; -SR 7 , -NHR 7 , -NR 7 R 8 ; C 1 -C 22 alkyl; C 2 -C 12 alkenyl; C 2 -C 12 alkinyl; C 3 -C 12 cycloalkyl; C 3 -C 12 cycloalkenyl; C 7 -C 12 aralkyl; C 1 -C 12 alkylphenyl; C 1 -C 12 alkoxy-C 6 -C 10 aryl; C 1 -C 12 heteroalkyl; C 2 -C 11 heteroaralkyl; C 3 -C 12 cycloheteroalkyl; C 6 -C 10 aryl; C 1 - C 12 alkoxy-C 6 -C 10 aryl; or C 1 -C 9 heteroaryl; R 6 is hydrogen; C 1 -C 22 alkyl; C 1 -C 22 alkoxy; or COR 7 ; R 7 and R 8 independently from each other are hydrogen; C 1 -C 22 alkyl; C 2 -C 12 alkenyl; C 2 -C 12 alkinyl; C 3 -C 12 cycloalkyl; C 3 -C 12 cycloalkenyl; -(CH 2 ) t COOH; C 7 -C 12 aralkyl; C 1 -C 12 heteroalkyl; C 2 -C 11 heteroaralkyl; C 6 -C 10 aryl; C 1 -C 9 heteroaryl; Si-R 10 R 11 R 12 ; Si(OR 10 )(OR 11 )(OR 12 ); SiR 10 (OR 11 )(OR 12 ); SiR 10 R 11 (OR 12 ); -(CH 2 ) u -O-(CH 2 ) v -SiR 10 R 11 R 12 ; or a radical X-Sil; t, u and v, independently from each other are a number from 1 to 5; R 9 is a (C 1 -C 6 )alkylidene radical; R 10 , R 11 , R 12 independently form each other are C 1 -C 22 alkyl; X is a linker; Sil is a silane-, oligosiloxane- or polysiloxane radical; R 1 and R 2 , R 1 and Q, R 1 and R 6 , R 1 and T, R 2 and R 3 , R 2 and R 4 , R 2 and R 6 , R 2 and Q, R 4 and R 6 , R 4 and T, R 6 and Q, T and Q, each independently, are linked together, so that 1, 2, 3 or 4 carbocyclic or N, O and/or S-heterocyclic rings are formed, wherein each of them, independently from each other, may be condensed with an aromatic or heteroaromatic ring, and/or more N-, O- and/or S-heterocyclic rings, and each N atom in a N-heterocyclic ring may be substituted by C 1 -C 22 alkyl; n is a number from 1 to 4; wherein at least one of the radicals R 1 , R 6 or Q is different from hydrogen; if n = 1 T is -COR 5 ; -CN; C 6 -C 10 aryl; -NHR 5 ; or -SO 2 -(C 6 -C 12 )aryl; R 2 and R 3 independently from each other are C 1 -C 22 alkyl; hydroxy-C 1 -C 22 alkyl; C 2 -C 12 alkenyl; C 2 -C 12 alkinyl; C 3 -C 12 cycloalkyl, C 3 -C 12 cycloalkenyl; C 7 -C 12 aralkyl; C 1 -C 12 heteroalkyl; C 3 -C 12 cycloheteroalkyl; C 6 -C 10 aryl; C 1 -C 9 heteroaryl; or a radical of formula (II); p is a number from 5 to 100; q is a number from 1 to 5; s is a number from 0 to 4; if n = 2 R 2 and R 3 are each C 1 -C 5 alkylene; and simultaneously T is defined as for n = 1; or T is a bivalent radical of formula -NR 7 -V-NR 7 -, wherin V is phenylene; or C 1 -C 5 alkylene; R 7 is hydrogen; or C 1 -C 5 alkyl; and R 2 and R 3 simultaneously are defined as for n = 1; if n = 3 one of R 2 , R 3 or T is a trivalent radical; if n = 4 one of R 2 , R 3 or T is a tetravalent radical; for protecting of human hair and skin against the damaging effect of UV radiation.